Company overview
Objective Biotechnology develops fully automated microinjection systems for large-scale genetic manipulation of cells and organisms, including the Autoinjector for precise embryo injections in gene editing and transgenesis. The technology uses machine learning and computer vision to enhance speed, consistency, and accessibility in genetic research across insect and vertebrate models. Based in Minneapolis, MN, the company supports researchers in streamlining complex protocols previously requiring extensive manual training.
Objective Biotechnology is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include automated microinjection, gene editing tools, genetic engineering, autoinjector, model organisms.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Objective Biotechnology include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.objectivebiotechnology.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- automated microinjection, gene editing tools, genetic engineering, autoinjector, model organisms
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What capabilities does Objective Biotechnology's Autoinjector provide?
- The Autoinjector automates microinjection for genetic engineering and gene editing in model organisms, enabling high-speed, precise embryo injections using machine learning and computer vision, with success in insect and vertebrate models.
- What regulatory or compliance features are offered?
- Objective Biotechnology's systems support consistent, high-quality results in research protocols, reducing training time from months to weeks, though specific regulatory certifications are not detailed in available information.
- Where is Objective Biotechnology located and what geographies do they serve?
- The company is based in Minneapolis, MN, USA, and offers products for global purchase directly from their website, with early access sites demonstrating use in 2024.
Related editorial coverage
- AstraZeneca's SAPHNELO Autoinjector Approved by FDA for Self-Administration in Lupus Treatment
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
